Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

COX-2-dependent cardiac failure in Gh/tTG transgenic mice.

Zhang Z, Vezza R, Plappert T, McNamara P, Lawson JA, Austin S, Praticò D, Sutton MS, FitzGerald GA.

Circ Res. 2003 May 30;92(10):1153-61. Epub 2003 Apr 17.

PMID:
12702643
2.

Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.

Vezza R, Mezzasoma AM, Venditti G, Gresele P.

Thromb Haemost. 2002 Jan;87(1):114-21.

PMID:
11848439
3.

Prostaglandin F(2alpha) receptor-dependent regulation of prostaglandin transport.

Vezza R, Rokach J, FitzGerald GA.

Mol Pharmacol. 2001 Jun;59(6):1506-13.

PMID:
11353812
4.

Directed vascular expression of the thromboxane A2 receptor results in intrauterine growth retardation.

Rocca B, Loeb AL, Strauss JF 3rd, Vezza R, Habib A, Li H, FitzGerald GA.

Nat Med. 2000 Feb;6(2):219-21.

PMID:
10655114
5.

Differential signaling by the thromboxane receptor isoforms via the novel GTP-binding protein, Gh.

Vezza R, Habib A, FitzGerald GA.

J Biol Chem. 1999 Apr 30;274(18):12774-9.

6.

Antivasoconstrictor and antiaggregatory activities of picotamide unrelated to thromboxane A2 antagonism.

Vezza R, Spina D, Tallarida RJ, Nathan M, Page CP, Gresele P.

Thromb Haemost. 1997 Nov;78(5):1385-91.

PMID:
9408024
7.

Rapid, agonist-dependent phosphorylation in vivo of human thromboxane receptor isoforms. Minimal involvement of protein kinase C.

Habib A, Vezza R, Créminon C, Maclouf J, FitzGerald GA.

J Biol Chem. 1997 Mar 14;272(11):7191-200.

8.

Regulation of cyclooxygenases by protein kinase C. Evidence against the importance of direct enzyme phosphorylation.

Vezza R, Habib A, Li H, Lawson JA, FitzGerald GA.

J Biol Chem. 1996 Nov 22;271(47):30028-33.

9.

Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets.

Iorio P, Gresele P, Stasi M, Nucciarelli F, Vezza R, Nenci GG, Goracci G.

FEBS Lett. 1996 Mar 4;381(3):244-8.

11.

Thrombocytopenia in HIV infected patients. Prevalence and clinical spectrum.

Marroni M, Gresele P, Vezza R, Papili R, Francisci D, De Socio G, Di Candilo F, Baldelli F, Fiorio M, Longo F, et al.

Recenti Prog Med. 1995 Mar;86(3):103-6.

PMID:
7754181
12.

Platelet glycohydrolase activities: characterization and release.

Emiliani C, Martino S, Orlacchio A, Vezza R, Nenci GG, Gresele P.

Cell Biochem Funct. 1995 Mar;13(1):31-9.

PMID:
7720188
13.

Interferon-alpha is effective in the treatment of HIV-1-related, severe, zidovudine-resistant thrombocytopenia. A prospective, placebo-controlled, double-blind trial.

Marroni M, Gresele P, Landonio G, Lazzarin A, Coen M, Vezza R, Sinnone MS, Boschetti E, Nosari AM, Stagni G, Nenci GG, Pauluzzi S.

Ann Intern Med. 1994 Sep 15;121(6):423-9.

PMID:
8053616
14.

[Pregnancy and labor in a primigravida with Glanzmann's thrombasthenia].

Pomili G, Servidio F, Vezza R, Ricotta S, Gresele P, Gilardi G.

Minerva Ginecol. 1994 Mar;46(3):129-32. Review. Italian.

PMID:
8015698
15.

Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C.

Vezza R, Roberti R, Nenci GG, Gresele P.

Blood. 1993 Nov 1;82(9):2704-13.

16.

Platelet thromboxane A2 receptor number and function in normal and hypertensive pregnancy.

Di Renzo GC, Coata G, De Franceschi S, Chiaradia E, Kett A, Vezza R, Nenci GG, Cosmi EV, Gresele P.

Am J Reprod Immunol. 1993 Sep-Oct;30(2-3):160-6.

PMID:
8311925
17.

Supplemental Content

Support Center